Literature DB >> 9541407

Structural and functional characterization of recombinant human cellular retinaldehyde-binding protein.

J W Crabb1, A Carlson, Y Chen, S Goldflam, R Intres, K A West, J D Hulmes, J T Kapron, L A Luck, J Horwitz, D Bok.   

Abstract

Cellular retinaldehyde-binding protein (CRALBP) is abundant in the retinal pigment epithelium (RPE) and Müller cells of the retina where it is thought to function in retinoid metabolism and visual pigment regeneration. The protein carries 11-cis-retinal and/or 11-cis-retinol as endogenous ligands in the RPE and retina and mutations in human CRALBP that destroy retinoid binding functionality have been linked to autosomal recessive retinitis pigmentosa. CRALBP is also present in brain without endogenous retinoids, suggesting other ligands and physiological roles exist for the protein. Human recombinant cellular retinaldehyde-binding protein (rCRALBP) has been over expressed as non-fusion and fusion proteins in Escherichia coli from pET3a and pET19b vectors, respectively. The recombinant proteins typically constitute 15-20% of the soluble bacterial lysate protein and after purification, yield about 3-8 mg per liter of bacterial culture. Liquid chromatography electrospray mass spectrometry, amino acid analysis, and Edman degradation were used to demonstrate that rCRALBP exhibits the correct primary structure and mass. Circular dichroism, retinoid HPLC, UV-visible absorption spectroscopy, and solution state 19F-NMR were used to characterize the secondary structure and retinoid binding properties of rCRALBP. Human rCRALBP appears virtually identical to bovine retinal CRALBP in terms of secondary structure, thermal stability, and stereoselective retinoid-binding properties. Ligand-dependent conformational changes appear to influence a newly detected difference in the bathochromic shift exhibited by bovine and human CRALBP when complexed with 9-cis-retinal. These recombinant preparations provide valid models for human CRALBP structure-function studies.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9541407      PMCID: PMC2143945          DOI: 10.1002/pro.5560070324

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  21 in total

1.  Analysis of the circular dichroism spectrum of proteins using the convex constraint algorithm: a practical guide.

Authors:  A Perczel; K Park; G D Fasman
Journal:  Anal Biochem       Date:  1992-05-15       Impact factor: 3.365

2.  Mutation of the gene encoding cellular retinaldehyde-binding protein in autosomal recessive retinitis pigmentosa.

Authors:  M A Maw; B Kennedy; A Knight; R Bridges; K E Roth; E J Mani; J K Mukkadan; D Nancarrow; J W Crabb; M J Denton
Journal:  Nat Genet       Date:  1997-10       Impact factor: 38.330

Review 3.  Methods for producing recombinant human cellular retinaldehyde-binding protein.

Authors:  J W Crabb; Y Chen; S Goldflam; K West; J Kapron
Journal:  Methods Mol Biol       Date:  1998

4.  Use of T7 RNA polymerase to direct expression of cloned genes.

Authors:  F W Studier; A H Rosenberg; J J Dunn; J W Dubendorff
Journal:  Methods Enzymol       Date:  1990       Impact factor: 1.600

5.  Cellular retinaldehyde-binding protein is expressed by oligodendrocytes in optic nerve and brain.

Authors:  J C Saari; J Huang; D E Possin; R N Fariss; J Leonard; G G Garwin; J W Crabb; A H Milam
Journal:  Glia       Date:  1997-11       Impact factor: 7.452

6.  Topological and epitope mapping of the cellular retinaldehyde-binding protein from retina.

Authors:  J W Crabb; V P Gaur; G G Garwin; S V Marx; C Chapline; C M Johnson; J C Saari
Journal:  J Biol Chem       Date:  1991-09-05       Impact factor: 5.157

7.  Crystallographic studies on a family of cellular lipophilic transport proteins. Refinement of P2 myelin protein and the structure determination and refinement of cellular retinol-binding protein in complex with all-trans-retinol.

Authors:  S W Cowan; M E Newcomer; T A Jones
Journal:  J Mol Biol       Date:  1993-04-20       Impact factor: 5.469

8.  Primary structure of alpha-tocopherol transfer protein from rat liver. Homology with cellular retinaldehyde-binding protein.

Authors:  Y Sato; H Arai; A Miyata; S Tokita; K Yamamoto; T Tanabe; K Inoue
Journal:  J Biol Chem       Date:  1993-08-25       Impact factor: 5.157

9.  Promotion of the release of 11-cis-retinal from cultured retinal pigment epithelium by interphotoreceptor retinoid-binding protein.

Authors:  A Carlson; D Bok
Journal:  Biochemistry       Date:  1992-09-22       Impact factor: 3.162

10.  Control of substrate flow at a branch in the visual cycle.

Authors:  J C Saari; D L Bredberg; N Noy
Journal:  Biochemistry       Date:  1994-03-15       Impact factor: 3.162

View more
  10 in total

1.  Hydroxynonenal inactivates cathepsin B by forming Michael adducts with active site residues.

Authors:  John W Crabb; June O'Neil; Masaru Miyagi; Karen West; Henry F Hoff
Journal:  Protein Sci       Date:  2002-04       Impact factor: 6.725

2.  Isomerization and oxidation of vitamin a in cone-dominant retinas: a novel pathway for visual-pigment regeneration in daylight.

Authors:  Nathan L Mata; Roxana A Radu; Richard C Clemmons; Gabriel H Travis
Journal:  Neuron       Date:  2002-09-26       Impact factor: 17.173

3.  Increasing the Stability of Recombinant Human Green Cone Pigment.

Authors:  Timothy S Owen; David Salom; Wenyu Sun; Krzysztof Palczewski
Journal:  Biochemistry       Date:  2018-01-29       Impact factor: 3.162

4.  A targeted approach to the identification of candidate genes determining susceptibility to Plasmodium gallinaceum in Aedes aegypti.

Authors:  I Morlais; A Mori; J R Schneider; D W Severson
Journal:  Mol Genet Genomics       Date:  2003-09-25       Impact factor: 3.291

5.  A cleavable affinity biotinylating agent reveals a retinoid binding role for RPE65.

Authors:  Wan Jin Jahng; Charles David; Nasri Nesnas; Koji Nakanishi; Robert R Rando
Journal:  Biochemistry       Date:  2003-05-27       Impact factor: 3.162

6.  Identification and quantification of glycoproteins using ion-pairing normal-phase liquid chromatography and mass spectrometry.

Authors:  Wen Ding; Harald Nothaft; Christine M Szymanski; John Kelly
Journal:  Mol Cell Proteomics       Date:  2009-06-12       Impact factor: 5.911

7.  Sodium channels enable fast electrical signaling and regulate phagocytosis in the retinal pigment epithelium.

Authors:  Julia K Johansson; Viivi I Karema-Jokinen; Satu Hakanen; Antti Jylhä; Hannu Uusitalo; Maija Vihinen-Ranta; Heli Skottman; Teemu O Ihalainen; Soile Nymark
Journal:  BMC Biol       Date:  2019-08-15       Impact factor: 7.431

8.  CRALBP is a highly prevalent autoantigen for human autoimmune uveitis.

Authors:  Cornelia A Deeg; Albert J Raith; Barbara Amann; John W Crabb; Stephan R Thurau; Stefanie M Hauck; Marius Ueffing; Gerhild Wildner; Manfred Stangassinger
Journal:  Clin Dev Immunol       Date:  2007

9.  Release of 11-cis-retinal from cellular retinaldehyde-binding protein by acidic lipids.

Authors:  John C Saari; Maria Nawrot; Ronald E Stenkamp; David C Teller; Gregory G Garwin
Journal:  Mol Vis       Date:  2009-04-23       Impact factor: 2.367

10.  The Concise Guide to PHARMACOLOGY 2013/14: overview.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; John C McGrath; William A Catterall; Michael Spedding; John A Peters; Anthony J Harmar; N Abul-Hasn; C M Anderson; C M H Anderson; M S Araiksinen; M Arita; E Arthofer; E L Barker; C Barratt; N M Barnes; R Bathgate; P M Beart; D Belelli; A J Bennett; N J M Birdsall; D Boison; T I Bonner; L Brailsford; S Bröer; P Brown; G Calo; W G Carter; W A Catterall; S L F Chan; M V Chao; N Chiang; A Christopoulos; J J Chun; J Cidlowski; D E Clapham; S Cockcroft; M A Connor; H M Cox; A Cuthbert; F M Dautzenberg; A P Davenport; P A Dawson; G Dent; J P Dijksterhuis; C T Dollery; A C Dolphin; M Donowitz; M L Dubocovich; L Eiden; K Eidne; B A Evans; D Fabbro; C Fahlke; R Farndale; G A Fitzgerald; T M Fong; C J Fowler; J R Fry; C D Funk; A H Futerman; V Ganapathy; B Gaisnier; M A Gershengorn; A Goldin; I D Goldman; A L Gundlach; B Hagenbuch; T G Hales; J R Hammond; M Hamon; J C Hancox; R L Hauger; D L Hay; A J Hobbs; M D Hollenberg; N D Holliday; D Hoyer; N A Hynes; K-I Inui; S Ishii; K A Jacobson; G E Jarvis; M F Jarvis; R Jensen; C E Jones; R L Jones; K Kaibuchi; Y Kanai; C Kennedy; I D Kerr; A A Khan; M J Klienz; J P Kukkonen; J Y Lapoint; R Leurs; E Lingueglia; J Lippiat; S J Lolait; S C R Lummis; J W Lynch; D MacEwan; J J Maguire; I L Marshall; J M May; C A McArdle; J C McGrath; M C Michel; N S Millar; L J Miller; V Mitolo; P N Monk; P K Moore; A J Moorhouse; B Mouillac; P M Murphy; R R Neubig; J Neumaier; B Niesler; A Obaidat; S Offermanns; E Ohlstein; M A Panaro; S Parsons; R G Pwrtwee; J Petersen; J-P Pin; D R Poyner; S Prigent; E R Prossnitz; N J Pyne; S Pyne; J G Quigley; R Ramachandran; E L Richelson; R E Roberts; R Roskoski; R A Ross; M Roth; G Rudnick; R M Ryan; S I Said; L Schild; G J Sanger; K Scholich; A Schousboe; G Schulte; S Schulz; C N Serhan; P M Sexton; D R Sibley; J M Siegel; G Singh; R Sitsapesan; T G Smart; D M Smith; T Soga; A Stahl; G Stewart; L A Stoddart; R J Summers; B Thorens; D T Thwaites; L Toll; J R Traynor; T B Usdin; R J Vandenberg; C Villalon; M Vore; S A Waldman; D T Ward; G B Willars; S J Wonnacott; E Wright; R D Ye; A Yonezawa; M Zimmermann
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.